Novo Nordisk reports DKK 15 billion buyback program update: stock pre-market at EUR 34.52
Published on 10/13/2026 at 08:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS- Novo Nordisk reported a share-repurchase update dated October 12, 2026.
- The overall buyback program has a DKK 15 billion ceiling.
- Lang & Schwarz showed the stock at EUR 34.52 at 8:11 a.m. CEST on October 13, 2026.
Novo Nordisk reported an update to its share-repurchase program on October 12, 2026. At 8:11 a.m. CEST on October 13, 2026, the stock was at EUR 34.52 in pre-market trading at Lang & Schwarz.
Pre-market indication
The Lang & Schwarz quote was EUR 34.52 at 8:11 a.m. CEST. The bid was EUR 34.48 and the ask was EUR 34.55. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Novo Nordisk stock.
Share-repurchase program
According to the Novo Nordisk release, the company’s overall share-repurchase program has a ceiling of DKK 15 billion and runs over a 12-month period beginning February 4, 2026. The update covered transactions made from October 5 through October 9, 2026.
The company said that 23,090,000 B shares had been repurchased under the program for a total transaction value of DKK 6,758,876,433. Novo Nordisk also reported 51,889,876 B shares held as treasury shares, corresponding to 1.2% of share capital.
What matters today
The repurchase program is scheduled to run through February 1, 2027. Novo Nordisk reported 51,889,876 treasury B shares, equal to 1.2% of share capital. The program’s overall ceiling is DKK 15 billion.
Market context: Latest market reports.
